The American College of Cardiology (ACC) and American Heart Association (AHA) have updated their hypertension guidelines to include renal denervation (RDN) as a treatment option for certain patients ...

MicroPort NeuroScientific has launched its Numen coil embolization system in Egypt through a partnership with PentaMed.

The FDA has granted breakthrough device designation to SpinaFX Medical’s Triojection system, a minimally invasive treatment for contained lumbar disc herniations.

Philips (NYSE: PHG) announced today that it plans to invest more than $150 million in U.S. manufacturing and R&D efforts.

Simpson Interventions announced today that investigators completed the first cases in a trial of its Acolyte catheter system.

Imperative Care announced today that it promoted Chuck Alpuche to the position of president and chief operating officer (COO).

Apple announced today that it plans to introduce a redesigned Blood Oxygen feature for some users of its Apple Watch devices.

Autonomix Medical (Nasdaq:AMIX) announced today that it advanced its proprietary sensing catheter through a final design ...

Apreo Health announced today that the first patient received treatment in a pivotal clinical trial for its Breathe airway scaffold device.

DeepSight Technology announced today that it received FDA 510(k) clearance for its NeedleVue LC1 ultrasound system.

Reprieve Cardiovascular announced today that it closed an oversubscribed Series B financing totaling $61 million.

Phyxiom, developer of a platform aiming to enhance asthma and COPD management, has announced its official launch.